Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Susanna Mannisto"'
Autor:
Suvi-Katri Leivonen, Marjukka Pollari, Oscar Brück, Teijo Pellinen, Matias Autio, Marja-Liisa Karjalainen-Lindsberg, Susanna Mannisto, Pirkko-Liisa Kellokumpu-Lehtinen, Olli Kallioniemi, Satu Mustjoki, Sirpa Leppä
Publikováno v:
Haematologica, Vol 104, Iss 2 (2019)
Primary testicular lymphoma is a rare lymphoid malignancy, most often, histologically, representing diffuse large B-cell lymphoma. The tumor microenvironment and limited immune surveillance have a major impact on diffuse large B-cell lymphoma pathoge
Externí odkaz:
https://doaj.org/article/08b8b45830b542eba13478c5f8b88e43
Autor:
Marjukka Pollari, Oscar Brück, Teijo Pellinen, Pauli Vähämurto, Marja-Liisa Karjalainen-Lindsberg, Susanna Mannisto, Olli Kallioniemi, Pirkko-Liisa Kellokumpu-Lehtinen, Satu Mustjoki, Suvi-Katri Leivonen, Sirpa Leppä
Publikováno v:
Haematologica, Vol 103, Iss 11 (2018)
Primary testicular lymphoma is a rare and aggressive lymphoid malignancy, most often representing diffuse large B-cell lymphoma histologically. Tumor-associated macrophages and tumor-infiltrating lymphocytes have been associated with survival in diff
Externí odkaz:
https://doaj.org/article/1611222594214f87b61bf144ea2082eb
Autor:
Sirpa Leppa, Judit M. Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Pedersen, Kristina Drott, Annika Pasanen, Kristiina Karihtala, Susanna Mannisto, Leo Meriranta, Bente Wold, Marianne Brodtkorb, Unn Merete Fagerli, Thomas S. Larsen, Lars Munksgaard, Kaisa Sunela, Øystein Fluge, Sirkku Jyrkkio, Peter de Nully Brown, Harald Holte
Publikováno v:
Blood. 140:1768-1769
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1874a85a267c9a743ae74b5e0dfeebe
https://doi.org/10.1182/blood-2022-158183
https://doi.org/10.1182/blood-2022-158183
Publikováno v:
Acta Oncologica. 59:660-665
Introduction: To minimize the radiation exposure of mostly young testicular cancer patients, it is essential to find out whether CT could be replaced by magnetic resonance imaging (MRI) in the stag...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1017aca89307f4029d0fe8a6f2e18a9
https://doi.org/10.1080/0284186x.2020.1725243
https://doi.org/10.1080/0284186x.2020.1725243
Autor:
Susanna Mannisto, Sirpa Leppä, Pauli Vähämurto, Marjukka Pollari, Michael Roost Clausen, Francesco d'Amore
Publikováno v:
Cancers
Vähämurto, P, Pollari, M, Clausen, M R, D’amore, F, Leppä, S & Mannisto, S 2020, ' Low absolute lymphocyte counts in the peripheral blood predict inferior survival and improve the international prognostic index in testicular diffuse large b-cell lymphoma ', Cancers, vol. 12, no. 7, 1967 . https://doi.org/10.3390/cancers12071967
Cancers, Vol 12, Iss 1967, p 1967 (2020)
Volume 12
Issue 7
Vähämurto, P, Pollari, M, Clausen, M R, D’amore, F, Leppä, S & Mannisto, S 2020, ' Low absolute lymphocyte counts in the peripheral blood predict inferior survival and improve the international prognostic index in testicular diffuse large b-cell lymphoma ', Cancers, vol. 12, no. 7, 1967 . https://doi.org/10.3390/cancers12071967
Cancers, Vol 12, Iss 1967, p 1967 (2020)
Volume 12
Issue 7
Low absolute lymphocyte counts (ALC) and high absolute monocyte counts (AMC) are associated with poor survival in patients with diffuse large B-cell lymphoma (DLBCL). We studied the prognostic impact of the ALC and AMC in patients with testicular DLB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ccb161ae5151e59de6f3aefbbc527f3
https://pubmed.ncbi.nlm.nih.gov/32698344
https://pubmed.ncbi.nlm.nih.gov/32698344
Autor:
Elisabeth Ralfkiaer, Sirpa Leppä, Klaus Beiske, Harald Holte, Thomas Stauffer Larsen, Mats Jerkeman, Judit Jørgensen, Unn-Merete Fagerli, Martin Maisenhölder, Marja-Liisa Karjalainen-Lindsberg, Signe Spetalen, Magnus Björkholm, Leo Meriranta, Lars Munksgaard, Øystein Fluge, Ingunn Østlie, Peter de Nully Brown, Knut Liestøl, Anne Tierens, Susanna Mannisto, Kaija Vasala, Sirkku Jyrkkiö, Peter Meyer
Publikováno v:
Leppä, S, Jørgensen, J, Tierens, A, Meriranta, L, Østlie, I, de Nully Brown, P, Fagerli, U M, Larsen, T S, Mannisto, S, Munksgaard, L, Maisenhölder, M, Vasala, K, Meyer, P, Jerkeman, M, Björkholm, M, Fluge, Ø, Jyrkkiö, S, Liestøl, K, Ralfkiaer, E, Spetalen, S, Beiske, K, Karjalainen-Lindsberg, M L & Holte, H 2020, ' Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis ', Blood advances, vol. 4, no. 9, pp. 1906-1915 . https://doi.org/10.1182/bloodadvances.2020001518
Leppä, S, Jørgensen, J, Tierens, A, Meriranta, L, Østlie, I, de Nully Brown, P, Fagerli, U-M, Larsen, T S, Mannisto, S, Munksgaard, L, Maisenhölder, M, Vasala, K, Meyer, P, Jerkeman, M, Björkholm, M, Fluge, Ø, Jyrkkiö, S, Liestøl, K, Ralfkiaer, E, Spetalen, S, Beiske, K, Karjalainen-Lindsberg, M-L & Holte, H 2020, ' Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis ', Blood Advances, vol. 4, no. 9, pp. 1906-1915 . https://doi.org/10.1182/bloodadvances.2020001518
Blood Advances
Blood Adv
Leppä, S, Jørgensen, J, Tierens, A, Meriranta, L, Østlie, I, de Nully Brown, P, Fagerli, U-M, Larsen, T S, Mannisto, S, Munksgaard, L, Maisenhölder, M, Vasala, K, Meyer, P, Jerkeman, M, Björkholm, M, Fluge, Ø, Jyrkkiö, S, Liestøl, K, Ralfkiaer, E, Spetalen, S, Beiske, K, Karjalainen-Lindsberg, M-L & Holte, H 2020, ' Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis ', Blood advances, vol. 4, no. 9, pp. 1906-1915 . https://doi.org/10.1182/bloodadvances.2020001518
Leppä, S, Jørgensen, J, Tierens, A, Meriranta, L, Østlie, I, de Nully Brown, P, Fagerli, U-M, Larsen, T S, Mannisto, S, Munksgaard, L, Maisenhölder, M, Vasala, K, Meyer, P, Jerkeman, M, Björkholm, M, Fluge, Ø, Jyrkkiö, S, Liestøl, K, Ralfkiaer, E, Spetalen, S, Beiske, K, Karjalainen-Lindsberg, M-L & Holte, H 2020, ' Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis ', Blood Advances, vol. 4, no. 9, pp. 1906-1915 . https://doi.org/10.1182/bloodadvances.2020001518
Blood Advances
Blood Adv
Leppä, S, Jørgensen, J, Tierens, A, Meriranta, L, Østlie, I, de Nully Brown, P, Fagerli, U-M, Larsen, T S, Mannisto, S, Munksgaard, L, Maisenhölder, M, Vasala, K, Meyer, P, Jerkeman, M, Björkholm, M, Fluge, Ø, Jyrkkiö, S, Liestøl, K, Ralfkiaer, E, Spetalen, S, Beiske, K, Karjalainen-Lindsberg, M-L & Holte, H 2020, ' Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis ', Blood advances, vol. 4, no. 9, pp. 1906-1915 . https://doi.org/10.1182/bloodadvances.2020001518
Survival of patients with high-risk diffuse large B-cell lymphoma (DLBCL) is suboptimal, and the risk of central nervous system (CNS) progression is relatively high. We conducted a phase 2 trial in 139 patients aged 18 to 64 years who had primary DLB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b8a880a8202aaafba6bd8012e2cb53b
https://findresearcher.sdu.dk:8443/ws/files/170252025/advancesadv2020001518.pdf
https://findresearcher.sdu.dk:8443/ws/files/170252025/advancesadv2020001518.pdf
Autor:
Emma I. Andersson, Sonja Lagström, Satu Mustjoki, Till Braun, Marco Herling, Panu E. Kovanen, Pekka Ellonen, Susanna Mannisto, Oscar Brück, Leena Saikko, Sirpa Leppä
Publikováno v:
Cancers
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 702 (2020)
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 702 (2020)
Peripheral T-cell lymphomas (PTCL) are a heterogeneous, and often aggressive group of non-Hodgkin lymphomas. Recent advances in the molecular and genetic characterization of PTCLs have helped to delineate differences and similarities between the vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85371b6252c5fe89c7398037f03c548f
Autor:
Olli Kallioniemi, Pirkko-Liisa Kellokumpu-Lehtinen, Satu Mustjoki, Pauli Vähämurto, Sirpa Leppä, Suvi-Katri Leivonen, Marja-Liisa Karjalainen-Lindsberg, Marjukka Pollari, Teijo Pellinen, Oscar Brück, Susanna Mannisto
Publikováno v:
Haematologica. 103:1908-1914
Primary testicular lymphoma is a rare and aggressive lymphoid malignancy, most often representing diffuse large B-cell lymphoma histologically. Tumor-associated macrophages and tumor-infiltrating lymphocytes have been associated with survival in diff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae67ace3911aaea3d393cbdef00d433c
https://doi.org/10.3324/haematol.2018.197194
https://doi.org/10.3324/haematol.2018.197194
Autor:
Pauli Vähämurto, Antti Mäkitie, Marjukka Pollari, Sirpa Leppä, Susanna Mannisto, Marja-Liisa Karjalainen-Lindsberg
Purpose Sinonasal tract diffuse large B-cell lymphoma (SNT-DLBCL), a rare extranodal lymphoma, is not well characterized. We performed a population-based study to determine cell-of-origin, clinical presentation and impact of rituximab (R) and central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b29734332df955dc0f12485cb7b4488
http://hdl.handle.net/10138/312895
http://hdl.handle.net/10138/312895
Autor:
Marja-Liisa Karjalainen-Lindsberg, Marjukka Pollari, Oscar Brück, Satu Mustjoki, Sirpa Leppä, Suvi-Katri Leivonen, Olli Kallioniemi, Pirkko-Liisa Kellokumpu-Lehtinen, Susanna Mannisto, Matias Autio, Teijo Pellinen
Publikováno v:
Haematologica
Primary testicular lymphoma is a rare lymphoid malignancy, most often, histologically, representing diffuse large B-cell lymphoma. The tumor microenvironment and limited immune surveillance have a major impact on diffuse large B-cell lymphoma pathoge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db9391c9156d4b2397db49f8598d2b44
http://hdl.handle.net/10138/300014
http://hdl.handle.net/10138/300014